Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
312 studies found for:    Open Studies | "Uterine Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer
Condition: Endometrial Neoplasm
Intervention: Procedure: Sentinel lymph node mapping
22 Recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus
Conditions: Complex Endometrial Hyperplasia With Atypia;   Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions: Drug: Levonorgestrel;   Drug: Metformin
23 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
24 Not yet recruiting Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy
Condition: Endometrial Polyps
Interventions: Procedure: Hysteroscopic morcellation;   Procedure: Standard hysteroscopic resection
25 Recruiting A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women
Condition: Adenocarcinoma of the Endometrium
Intervention: Drug: Metformin
26 Not yet recruiting Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Conditions: Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Study of Socioeconomic and Demographic Variables
27 Not yet recruiting Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: Recurrent Uterine Corpus Carcinoma;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
28 Not yet recruiting Natural Supplements and a Special Diet in Eliminating Cancer-impacting Hormones From Sources Outside the Body in Patients With Early-Stage or Remission Prostate Cancer, Breast Cancer, or Uterine Cancer
Conditions: Breast Cancer;   Prostate Cancer;   Sarcoma
Interventions: Other: laboratory biomarker analysis;   Procedure: therapeutic dietary intervention
29 Not yet recruiting Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Conditions: Cervical Cancer;   Ovarian Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulval Cancer;   Psychosexual Dysfunctions
Intervention: Behavioral: SAFFRON stepped care
30 Not yet recruiting Biomarkers in Samples From Patients With Endometrial Cancer
Conditions: Lynch Syndrome;   Recurrent Uterine Corpus Carcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
31 Not yet recruiting Pembro/Carbo/Taxol in Endometrial Cancer
Conditions: Endometrial Cancer;   Endometrial Adenocarcinoma
Interventions: Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: Carboplatin
32 Recruiting Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Condition: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
Intervention: Radiation: Radiotherapy
33 Recruiting Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma
Conditions: Endometrial Atypical Hyperplasia;   Endometrial Adenocarcinoma
Interventions: Drug: Megestrol acetate and metformin;   Drug: Megestrol acetate
34 Not yet recruiting Prognostic Biomarkers in Patients With Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma;   Stage I Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Intervention: Other: Laboratory Biomarker Analysis
35 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Internal Radiation Therapy;   Radiation: External Beam Radiation Therapy;   Other: Laboratory Biomarker Analysis
36 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
37 Recruiting Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Lung Cancer;   Melanoma;   Non-Hodgkin's Lymphoma;   Uterine Cancer;   CORPUS UTERI,ENDOMETRIUM;   LUNG;   OVARY
Intervention:
38 Recruiting Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Conditions: Advanced Malignant Neoplasm;   Cervical Squamous Cell Carcinoma;   Endometrial Carcinoma;   Malignant Uterine Neoplasm;   Recurrent Bladder Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Ovarian Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Renal Cell Carcinoma;   Solid Neoplasm;   Stage III Bladder Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Breast Cancer;   Stage IV Ovarian Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Bladder Cancer;   Stage IVA Cervical Cancer;   Stage IVB Bladder Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nanoparticle Albumin-Bound Rapamycin;   Other: Quality-of-Life Assessment
39 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
40 Recruiting Prospective Analysis of Robot-Assisted Surgery
Conditions: Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Rectal Cancer;   Bladder Cancer;   Prostate Cancer;   Renal Cancer;   Uterus Cancer;   Head and Neck Cancer;   Lung Cancer
Interventions: Procedure: Robot-assisted surgery;   Procedure: Conventional Surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.